We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

5711:TSEMitsubishi Materials Corp. Analysis

Data as of 2026-06-11 - not real-time

€18.68

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The stock trades above its short‑term moving averages and the MACD histogram is positive, suggesting short‑term bullish momentum, while the RSI sits in a neutral zone. Volatility remains elevated and beta is negative, indicating low correlation with broader market moves.
Valuation and fundamentals: The price‑earnings multiple sits above the sector average and the discounted‑cash‑flow estimate is well below the current market price, pointing to an overvalued situation. The dividend yield is attractive but the payout ratio exceeds earnings, raising concerns about sustainability. Strong operating margins and robust cash flow support the business, yet leverage is high with a debt‑to‑equity ratio that far exceeds typical midstream peers. Strategic considerations: Revenue growth is solid and the company benefits from stable midstream contracts, but concentration in the Appalachian Basin adds geographic exposure and regulatory scrutiny around water handling intensifies. Overall, the blend of bullish technical signals and fundamental overvaluation suggests a cautious stance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish short‑term technical indicators
  • Elevated volatility and low market correlation
  • Overvaluation signals temper optimism

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Solid revenue growth and high operating margins
  • High leverage and unsustainable dividend payout
  • Midstream cash‑flow stability offset by valuation concerns

Long Term

> 3 years
Cautious
Model confidence: 7/10

Key Factors

  • Persistent overvaluation relative to intrinsic estimates
  • Debt load and payout ratio raise financial strain
  • Regulatory and geographic concentration risks

Key Metrics & Analysis

Financial Health

Revenue Growth8.60%
Profit Margin31.94%
P/E Ratio24.9
ROE20.41%
ROA7.61%
Debt/Equity191.72
P/B Ratio5.3
Op. Cash Flow€972.1M
Free Cash Flow€457.1M
Industry P/E21.8

Technical Analysis

TrendBullish
RSI54.0
Support€17.35
Resistance€19.26
MA 20€18.52
MA 50€18.51
MA 200€16.86
MACDBullish
VolumeDecreasing
Fear & Greed Index81.75

Valuation

Fair Value€10.32
GradeOvervalued
TypeBlend
Dividend Yield4.18%

Risk Assessment

Beta-0.39
Volatility26.66%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.